 SAN DIEGO, June 07, 2022 GLOBE NEWSWIRE -- Longboard Pharmaceuticals, Inc. Nasdaq: LBPH, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin Lind, Longboards President CEO, will present at the JMP Securities Life Sciences Conference on June 15, 2022, at 3:00PM ET, in New York City. 